BE606643A - New drug for the treatment of migraines of hepatic origin and in general hepatic disorders - Google Patents

New drug for the treatment of migraines of hepatic origin and in general hepatic disorders

Info

Publication number
BE606643A
BE606643A BE606643A BE606643A BE606643A BE 606643 A BE606643 A BE 606643A BE 606643 A BE606643 A BE 606643A BE 606643 A BE606643 A BE 606643A BE 606643 A BE606643 A BE 606643A
Authority
BE
Belgium
Prior art keywords
hepatic
migraines
treatment
new drug
general
Prior art date
Application number
BE606643A
Other languages
French (fr)
Original Assignee
Cfmc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cfmc filed Critical Cfmc
Publication of BE606643A publication Critical patent/BE606643A/en

Links

BE606643A 1960-07-29 1961-07-27 New drug for the treatment of migraines of hepatic origin and in general hepatic disorders BE606643A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR606643X 1960-07-29

Publications (1)

Publication Number Publication Date
BE606643A true BE606643A (en) 1962-01-29

Family

ID=39320054

Family Applications (1)

Application Number Title Priority Date Filing Date
BE606643A BE606643A (en) 1960-07-29 1961-07-27 New drug for the treatment of migraines of hepatic origin and in general hepatic disorders

Country Status (1)

Country Link
BE (1) BE606643A (en)

Similar Documents

Publication Publication Date Title
BE773910A (en) COMPOSITION FOR THE TREATMENT OF HEPATIC DISORDERS AND INTELLECTUAL OVEREXAMPLE
FR3851M (en) New drug in particular for the treatment of hypercholesterolemia and the resulting disorders.
FR139M (en) New drug for the treatment of migraines of hepatic origin and in general hepatic disorders.
BE606643A (en) New drug for the treatment of migraines of hepatic origin and in general hepatic disorders
FR3845M (en) New drug in particular for the treatment of hypercholesterolemia and the resulting disorders.
FR1323056A (en) Method and composition for coating pharmaceutical tablets
FR1438M (en) New drug effective in the treatment of atherosclerosis.
FR1329885A (en) Device for detecting the stop of rhythmic movements and in particular respiratory movements
BE605476A (en) Veterinary composition for the treatment of enterohepatitis in turkeys
FR1187M (en) New drug in particular for the treatment of inflammatory manifestations of arthritic or infectious rheumatic origin.
FR151M (en) New drug, in particular for the treatment of neuro-depressive states and anxiety psychoses.
FR2929M (en) Pharmaceutical composition for the treatment of arthritic and rheumatic conditions.
FR1857M (en) New drug in particular for the treatment of diseases of viral origin.
FR37M (en) New drug in particular for the treatment of inflammatory phenomena of rheumatic, arthritic or hepatic origin.
FR2974M (en) New drug in particular for the treatment of spasms of coronary origin and circulatory disorders.
FR1594M (en) New drug in particular for the treatment of hypercholesterolemia and disorders due to acute or chronic hyperlipemia.
BE598672A (en) Therapeutic composition for the treatment of hepatic disorders.
FR2789M (en) New drug in particular for the treatment of hypercholesterolemia and the resulting disorders.
FR1764M (en) New drug in particular for the treatment of spasms of coronary or visceral origin.
FR1780M (en) New drug in particular for the treatment of disorders of protein anabolism.
FR3031M (en) New drug in particular for the treatment of hypercholesterolemia and the resulting disorders.
FR16M (en) New drug in particular for the treatment of inflammatory phenomena of rheumatic, arthritic or hepatic origin.
FR2467M (en) New drug in particular for the treatment of neuro-depressive states and anxiety psychoses.
FR1484M (en) New drug in particular for the treatment of inflammatory manifestations of microbial origin.
FR1485M (en) New drug in particular for the treatment of hyper cholesterolemia and the resulting disorders.